Search the Newsreel

How Ibotta Inc. Class A (IBTA) Affects Rotational Strategy Timing

This article analyzes Ibotta Inc. Class A (IBTA) using AI models to determine its impact on rotational strategy timing. It highlights strong sentiment across all horizons, indicating an overweight bias, and presents three distinct trading strategies: Position Trading, Momentum Breakout, and Risk Hedging. The …

PROCEPT BioRobotics (PRCT) grants RSUs and options to Chief Strategy & Marketing Officer

PROCEPT BioRobotics (PRCT) granted its Chief Strategy & Marketing Officer, Pooja Sharma, 23,622 restricted stock units (RSUs) and an option to purchase 32,681 shares at an exercise price of $21.95 on August 13, 2026. These equity awards are intended to represent 50% of her …

Lifeward Revenue Rises 16% to $6.6 Million in Second Quarter 2026

Lifeward Ltd. (LFWD) reported a 16% increase in second-quarter 2026 revenue, reaching $6.6 million, driven by strong sales of ReWalk Personal exoskeletons and AlterG products. Despite the revenue growth, the company posted an $11.5 million GAAP net loss. Several key executives and directors departed, …

Affordable Robotic Q1 Results: Revenue rises 11% YoY to ₹4.50 crore

Park National Corp OH Lowers Stake in Abbott Laboratories $ABT

Park National Corp OH reduced its stake in Abbott Laboratories by 10.2% in the second quarter, selling 17,000 shares but still retaining 150,182 shares valued at approximately $13.6 million. Despite this reduction and some analysts lowering price targets, the consensus rating for Abbott remains …

QRG Capital Management Inc. Lowers Holdings in Abbott Laboratories $ABT

QRG Capital Management Inc. reduced its stake in Abbott Laboratories (NYSE:ABT) by 28.7% in the second quarter, selling 83,416 shares and retaining 207,173 shares worth approximately $18.8 million. Despite this reduction, institutional investors collectively own 75.18% of ABT. Abbott Laboratories recently reported stronger-than-expected quarterly …

(AKO.A) Risk Channels and Responsive Allocation

This article analyzes Embotelladora Andina S.a. (NASDAQ: AKO.A) with a near-term neutral sentiment, despite mid and long-term strength. It highlights an exceptional risk-reward short setup and provides three distinct AI-generated trading strategies tailored to different risk profiles and holding periods, focusing on position trading, …

Lifeward (LFWD) grows Q2 2026 revenue 16% as net loss deepens on non-cash charges

Lifeward (LFWD) reported a 16% increase in Q2 2026 revenue to $6.6 million, driven by strong sales of ReWalk Personal exoskeletons and AlterG products. Despite an improvement in operating loss, the GAAP net loss widened to $11.5 million due to non-cash fair value charges …

Abbott Laboratories Revenue Breakdown – AQUISUK:ABLD

This article provides a revenue breakdown for Abbott Laboratories (ABLD) on the Aquis Stock Exchange. It highlights that in the last year, the company generated 37.74 billion EUR, with Medical Devices being the top-performing segment at 18.21 billion EUR. The United States was the …

Can Abbott Laboratories (ABT)’s Lingo Partnership With Alphabet (GOOG) Unlock a New Era of AI-Powered Health?

On August 11, medtech leader Abbott Laboratories (NYSE:ABT) and tech behemoth Alphabet Inc. (NASDAQ:GOOG) announced a multi-year partnership to unite continuous glucose monitoring with consumer AI. The collaboration embeds data from Abbott's non-prescription Lingo biowearable directly into the Google Health app, combining real-time metabolic …

IBTA Q2 2026 Earnings: Loss Narrows Sharply as EPS Beats Estimates by 75.7% - Profit Recovery Report

Microbot Medical (MBOT) Drops 7.7% to $1.55, Nearing Key Support at $1.47 - Liquidity Order Flow

fuboTV (NYSE:FUBO) Posts Earnings Results, Beats Expectations By $0.04 EPS

Richtech Robotics (RR) flags $9.8M software impairment in delayed 10-Q

AMC Robotics (AMCI) revenue falls as margins rise and losses shrink

AMC Robotics (AMCI) reported a decline in revenue for the three and six months ended June 30, 2026, primarily due to decreased hardware sales to related parties, though revenue-share with Kami increased. Despite lower top-line figures, the company significantly improved its gross profit and …

PROCEPT BioRobotics (PRCT) awards RSUs and stock options to CFO Kevin Waters

PROCEPT BioRobotics (PRCT) has granted its EVP and CFO, Kevin Waters, 29,527 Restricted Stock Units (RSUs) and a stock option for 40,851 shares. These awards, granted on August 13, 2026, are intended to represent 50% of the value of Waters' expected 2027 equity compensation. …

PROCEPT BioRobotics (PRCT) awards stock options and RSUs to EVP CTO Templin

PROCEPT BioRobotics has granted its EVP and CTO, Barry L. Templin, 36,312 stock options with an exercise price of $21.95 and 26,246 restricted stock units (RSUs). These equity awards, dated August 13, 2026, are part of his compensation, vesting over four years subject to …

AMC Robotics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

AMC Robotics reported its second quarter 2026 financial results, highlighting a strategic shift towards higher-margin AI and cloud services, which expanded gross margin to 80%. The company announced a new manufacturing facility in Vietnam for NovaArm™ production targeting a H2 2026 launch and made …

PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and Approximately 18% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Kahn Swick & Foti, LLC (KSF) is reminding investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) who incurred substantial losses to file lead plaintiff applications by September 22, 2026. This securities class action lawsuit alleges that Procept and its executives failed to disclose material information …

American Century entities (CBT) disclose over 5% ownership in Cabot Corporation

American Century ETF Trust and its affiliated entities have disclosed beneficial ownership exceeding 5% in Cabot Corporation common stock. American Century ETF Trust holds 2,640,178 shares, representing 5.1% of the outstanding common stock, while American Century Investment Management, Inc., American Century Companies, Inc., and …

Trading the Move, Not the Narrative: (AKO.B) Edition

This article provides a detailed analysis of Embotelladora Andina S.a. (NASDAQ: AKO.B), highlighting weak near-term sentiment but strong mid and long-term outlooks. It presents three distinct AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—tailored to different risk profiles, along with support and resistance levels …

Freedom Broker upgrades Serve Robotics stock rating to buy despite weak Q2

Freedom Broker upgraded Serve Robotics (NASDAQ:SERV) to Buy from Hold, setting a new price target of $8.00 despite the company's weak Q2 fiscal 2026 results and reduced revenue guidance. The company reported significant revenue growth but also widening net losses and declining daily active …

Serve Robotics upgraded to Buy as valuation turns attractive (SERV:NASDAQ)

Die Abbott-Laboratories-Aktie legt nach starker Q2-Guidance moderat zu

Can Serve Robotics Scale Physical AI Beyond Food Delivery in 2026?

Serve Robotics (SERV) is transitioning from a food delivery service to a broader Physical AI platform, expanding into healthcare, advertising, and software. Despite lowering its 2026 revenue guidance due to unmaterialized Uber delivery growth, the company is focusing on healthcare robotics and developing new …

Lifeward Ltd. 2026: Revenue $6.62M, Net income ($11.52M), EPS ($4.12) — 10-Q Summary

Lifeward Ltd. reported its 2026 quarterly results, showing a 15.7% year-over-year revenue increase to $6.62 million, driven by higher AlterG shipments and stronger ReWalk sales. Despite the revenue growth, the company recorded a net loss of ($11.52 million) and diluted loss per share of …

Lifeward (LFWD) Reports Q2 Loss, Misses Revenue Estimates

Lifeward (NASDAQ: LFWD) doubles H1 loss and warns on going concern as it adds debt

Abbott Laboratories: Revenue and Earnings Analysts Forecasts Revisions | ABT | US0028241000

Is Lifeward Ltd (LFWD) Positioned for Growth After Q2 Earnings?

Abbott India Shares Fall Over 2%

Thompson Investment Management Inc. Has $1.28 Million Stock Position in Abbott Laboratories $ABT

Toth Financial Advisory Corp Decreases Stock Holdings in Abbott Laboratories $ABT

Abbott Laboratories $ABT Shares Sold by Cox Capital Mgt LLC

West Branch Capital LLC significantly reduced its stake in Abbott Laboratories (NYSE:ABT) by 83.5% in the second quarter, selling 13,061 shares and retaining 2,576 shares worth $234,000. Despite this sell-off, institutional investors collectively own 75.18% of Abbott’s stock. Abbott reported strong Q2 earnings of …

Symbotic (SYM) On Strong Q3 And New Guidance, Is The Bull Case Already Priced In?

Serve Robotics didn’t expect Uber to sell its entire stake

Serve Robotics was surprised to learn that Uber Technologies sold its entire stake in the company, a divestment disclosed in a regulatory filing. This move coincided with a decrease in delivery volumes through Uber for Serve, the first such decline after 17 quarters of …